Progressive
Care Inc. Garners Coverage in The Pot.Live Podcast
MIAMI – October 22, 2019 --
InvestorsHub NewsWire -- Progressive
Care Inc. (OTCQB:
RXMD),
a personalized healthcare services and technology company, today
announced that Shital Mars, CEO of Progressive Care Inc., was
featured on
The Pot.Live Podcast.
"It is an honor
to speak with the team at The Pot.Live Podcast regarding the topic
of our companies latest educational initiatives on informing
consumers about CBD and cannabis-based medicines" said S. Parikh
Mars, CEO of Progressive Care Inc. "This podcast comes after our
recent announcement regarding the formation of RXMD Therapeutics
Inc., which will specialize in cannabinoid-based and alternative
nutraceutical products. Our mission is to educate customers on CBD
and its benefits while also explaining how to properly take it in
conjunction with other medicines."
In
the podcast titled CBD
and cannabis Based Medicine with Shital Mars,
published October 16, 2019, on The Pot.Live Podcast, Mars talks in
detail about the trending momentum of CBD, how individuals can
incorporate CBD with their prescription medications, proper dosing,
the difference between mechanisms, and the formation of RXMD
Therapeutics Inc. Mars starts things off by explaining how
individuals can incorporate CBD with their prescribed medicines,
"If you are using prescription grade pain relievers, CBD can help
you use less or you may not even need them at all. Be mindful that
CBD doesn't work for everybody across the board. If you are still
struggling with sleep and inflammation, then there is nothing wrong
with turning to traditional medicine to get the relief that you
need. CBD is a great place to start and a lot of people can benefit
from it."
Mars
goes on to discuss how CBD works differently for each person and
touches on the different delivery mechanisms that Progressive Care
Inc. has seen work the best, "There is complete flexibility on the
best delivery mechanism for each person, one size does not fit all.
Our company has seen that patients who suffer from shoulder
inflammation or rheumatoid arthritis benefit from a topical which
directly addresses the area of need. If a patient has arthritis
throughout the whole body, a tincture, edible or capsule will be
the most effective delivery system but will have a less systemic
absorption and longer-acting affects. A sublingual or a tincture
under the tongue tend to also have quicker effects but the effects
do not last as long. I suggest that patients start with a low dose,
build-up, find a place that works, and then stick with what you
know works and with a brand that you know you can trust. The big
key in all of this is to make sure that you are using a CBD product
that has a reputable website, offers a Certificate of Analysis, and
a brand that is transparent about what is in the
product."
Mars
speaks on the benefits of using traditional cannabis with THC to
get CBD absorbed into the endocannabinoid system, "We recommend
that if you're using marijuana medicinally, to do that under the
guidance of a reputable physician or pharmacist who can guide you
on how to properly use it. Overall, we need to stop vilifying
marijuana because it does have medicinal effects and can be
beneficial for a wide range of issues. Over time, we hope to see
these laws change to bring natural remedies to the forefront
through regulation so that patients can start receiving the
medicinal benefits and not feel the need to turn to
anti-depressants or opioids."
When
asked about the initial product line of RXMD Therapeutics, Mars
explains why they created their own CBD offerings, "It is our goal
to provide a trusted source to patients where they can get hands-on
knowledge and expertise from pharmacists that can guide them on how
to use it for particular ailments. We want to make sure that we're
educating patients on how CBD works for their body and interacting
with other medications that they may be taking. Our goal is for
patients to use CBD medicinally and to have us monitor that therapy
throughout their use. "
The recent media
coverage comes after the company's efforts to provide its network
with more healthcare informational resources through PharmCo
Pharmacy.
Additional commentary from Progressive Care's CEO about the company
and industry as a whole can be found on the Progressive
Care blog and PharmCo
blog.
For more
immediate updates on the company's media coverage, connect with
Progressive Care and PharmCo on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About
Progressive Care Inc.
Progressive Care
Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a
South Florida health services organization and provider of
prescription pharmaceuticals, compounded medications, provider of
tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription
medications to long-term care facilities, and health practice risk
management.
Cautionary Statement Regarding Forward-Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance, and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Public
Relations Contact:
Caitlin
Franscell, CMW Media
caitlin@cmwmedia.com
www.cmwmedia.com
Investor
Relations Contact:
Armen Karapetyan,
Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com